Spontaneous isolated superior mesenteric artery dissection
Conditions
Interventions
endovascular therapy Group:endovascular therapy
medical therapy group:medical therapy
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) SISMAD diagnosed by CTA/DSA; 2) The patient agrees and signs the informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients with mental illness or unable to cooperate; 2) Asymptomatic SISMAD; 3) Patients with signs of peritonitis or Severe intestinal ischemia; 4) Patients with strangulated intestinal obstruction; 5) Patients who plan to receive open surgery; 6) Lactating or pregnant women, or women/men who plan to have child recently; 7) Life expectancy =2.5mg/dL within 30 days before surgery, or receive dialysis treatment); 12) Active systemic infection or uncontrolled coagulation dysfunction within 14 days before surgery; 13) Previous target vascular surgery history; 14) Inability to take medications as prescribed, or to comply with preoperative and postoperative medication requirements due to allergy to antiplatelet drugs (aspirin or clopidogrel), lmheparin, and vasodilators or contrast agents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year reintervention rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom remission rate;Imaging outcome;Re-Intervention rate;disease-related adverse events; | — |
Countries
China
Contacts
Public ContactJichun Zhao
Department of Vascular Surgery, West China Hospital, Sichuan University
Outcome results
None listed